See more : Ganga Pharmaceuticals Limited (GANGAPHARM.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Palomar Holdings, Inc. (PLMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Palomar Holdings, Inc., a leading company in the Insurance – Property & Casualty industry within the Financial Services sector.
- CHC Resources Corporation (9930.TW) Income Statement Analysis – Financial Results
- CURO Group Holdings Corp. (CUROQ) Income Statement Analysis – Financial Results
- Unieuro S.p.A. (UNIR.MI) Income Statement Analysis – Financial Results
- Shenzhen Jianyi Decoration Group Co., Ltd. (002789.SZ) Income Statement Analysis – Financial Results
- Cambridge Technology Enterprises Limited (CTE.NS) Income Statement Analysis – Financial Results
Palomar Holdings, Inc. (PLMR)
About Palomar Holdings, Inc.
Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers. The company offers personal and commercial specialty property insurance products, including residential and commercial earthquake, commercial all risk, specialty homeowners, inland marine, Hawaii hurricane, and residential flood, as well as other products, such as assumed reinsurance, commercial flood, real estate error and omission, and real estate investor products. It markets and distributes its products through retail agents, wholesale brokers, program administrators, and carrier partnerships. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 375.93M | 327.09M | 247.79M | 168.46M | 113.30M | 72.97M | 59.47M | 42.70M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 375.93M | 327.09M | 247.79M | 168.46M | 113.30M | 72.97M | 59.47M | 42.70M |
Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 11.62M | 5.58M | 2.17M | 24.10M | 0.00 | 0.00 | 0.00 |
Other Expenses | 375.93M | 259.54M | -190.65M | -162.24M | -95.22M | -52.46M | -52.79M | -34.79M |
Operating Expenses | 375.93M | 259.54M | -190.65M | -162.24M | -95.22M | -52.46M | -52.79M | -34.79M |
Cost & Expenses | 268.51M | 259.54M | 190.65M | 162.24M | 95.22M | 54.76M | 54.54M | 36.42M |
Interest Income | 0.00 | 14.37M | 9.58M | 9.04M | 6.32M | 3.55M | 2.43M | 1.90M |
Interest Expense | 3.78M | 873.00K | 40.00K | 0.00 | 1.07M | 2.30M | 1.75M | 1.63M |
Depreciation & Amortization | 4.50M | 4.12M | 3.54M | 1.34M | 216.00K | 212.00K | 160.00K | 88.00K |
EBITDA | 111.92M | 72.54M | 60.68M | 7.56M | 19.36M | 20.73M | 6.83M | 8.00M |
EBITDA Ratio | 29.77% | 22.67% | 24.49% | 4.49% | 16.15% | 28.41% | 11.49% | 18.73% |
Operating Income | 107.42M | 68.42M | 57.14M | 6.22M | 18.08M | 20.52M | 6.67M | 7.91M |
Operating Income Ratio | 28.57% | 20.92% | 23.06% | 3.69% | 15.96% | 28.12% | 11.22% | 18.53% |
Total Other Income/Expenses | -3.78M | -873.00K | -381.31M | 0.00 | -1.07M | -2.30M | -1.75M | -1.63M |
Income Before Tax | 103.64M | 67.55M | 57.14M | 6.22M | 18.08M | 18.21M | 4.93M | 6.28M |
Income Before Tax Ratio | 27.57% | 20.65% | 23.06% | 3.69% | 15.96% | 24.96% | 8.29% | 14.70% |
Income Tax Expense | 24.44M | 15.38M | 11.29M | -34.00K | 7.46M | -6.00K | 1.15M | -337.00K |
Net Income | 79.20M | 52.17M | 45.85M | 6.26M | 10.62M | 18.22M | 3.78M | 6.61M |
Net Income Ratio | 21.07% | 15.95% | 18.50% | 3.71% | 9.37% | 24.97% | 6.36% | 15.49% |
EPS | 3.19 | 2.07 | 1.80 | 0.25 | 0.49 | 0.81 | 0.17 | 0.29 |
EPS Diluted | 3.13 | 2.02 | 1.76 | 0.24 | 0.49 | 0.81 | 0.17 | 0.29 |
Weighted Avg Shares Out | 24.82M | 25.24M | 25.46M | 24.87M | 21.50M | 22.63M | 17.20M | 17.00M |
Weighted Avg Shares Out (Dil) | 25.33M | 25.80M | 26.11M | 25.60M | 21.83M | 22.63M | 22.63M | 22.63M |
Why Is Palomar (PLMR) Up 19.8% Since Last Earnings Report?
Palomar Holdings Stock Surges 86.8% YTD: Will the Rally Last?
Palomar Holdings, Inc. Appoints Benson Latham EVP, Head of Crop
Palomar Holdings, Inc. (PLMR) Q3 2024 Earnings Call Transcript
Palomar Q3 Earnings, Revenues Top Estimates on Higher Premiums
Palomar (PLMR) Reports Q3 Earnings: What Key Metrics Have to Say
Palomar (PLMR) Beats Q3 Earnings and Revenue Estimates
Palomar Holdings, Inc. Reports Third Quarter 2024 Results
Palomar Holdings, Inc. Announces Third Quarter 2024 Financial Results Release Date and Conference Call
Palomar Health and Palomar Health Medical Group Partner With IKS Health to Leverage Cutting-Edge Healthcare Technology and Services to Drive a Holistic Transformation
Source: https://incomestatements.info
Category: Stock Reports